These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20853592)

  • 1. Treatment of hepatitis C 2010: a focus on protease inhibitors.
    Lemon M
    S D Med; 2010 Jun; 63(6):214-5. PubMed ID: 20853592
    [No Abstract]   [Full Text] [Related]  

  • 2. Excitement grows for potential revolution in hepatitis C virus treatment.
    Opar A
    Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
    [No Abstract]   [Full Text] [Related]  

  • 3. Prisoners treated for hepatitis C with protease inhibitor, New York, USA, 2012.
    Moorjani H; Koenigsmann C; Kim MJ; Spaulding AC
    Emerg Infect Dis; 2015 Jan; 21(1):186-8. PubMed ID: 25531029
    [No Abstract]   [Full Text] [Related]  

  • 4. Worth the wait. New, more effective therapies for hepatitis C are on the way.
    Learned J
    Posit Aware; 2011; 23(1):15-8. PubMed ID: 21314021
    [No Abstract]   [Full Text] [Related]  

  • 5. Interim results presented at EASL from PROVE 1 clinical trial of investigational drug telaprevir in patients with genotype 1 hepatitis C.
    Lang L
    Gastroenterology; 2007 Jun; 132(7):2283-4. PubMed ID: 17570199
    [No Abstract]   [Full Text] [Related]  

  • 6. New hepatitis C regimen stimulates changes in therapy management.
    Reinke T
    Manag Care; 2011 Dec; 20(12):41-2. PubMed ID: 22259876
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
    Manns M
    MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
    [No Abstract]   [Full Text] [Related]  

  • 8. Protease inhibitors in hepatitis C: from chronic disease to cure.
    Iqbal M; McCormick PA
    Ir Med J; 2011 Sep; 104(8):230-1. PubMed ID: 22125874
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C virus therapies.
    Smith RE
    Nat Rev Drug Discov; 2006 Sep; 5(9):715-6. PubMed ID: 17001802
    [No Abstract]   [Full Text] [Related]  

  • 10. PROVE data released on telaprevir.
    AIDS Patient Care STDS; 2007 May; 21(5):369. PubMed ID: 17518530
    [No Abstract]   [Full Text] [Related]  

  • 11. Telaprevir: hope on the horizon, getting closer.
    Weisberg IS; Jacobson IM
    Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects.
    Bartels DJ; Zhou Y; Zhang EZ; Marcial M; Byrn RA; Pfeiffer T; Tigges AM; Adiwijaya BS; Lin C; Kwong AD; Kieffer TL
    J Infect Dis; 2008 Sep; 198(6):800-7. PubMed ID: 18637752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A promising new anti-HCV protease inhibitor.
    Sulkowski M
    Hopkins HIV Rep; 2003 Jan; 15(1):7. PubMed ID: 12542005
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of HCV protease inhibitors.
    Chen KX; Njoroge FG
    Curr Opin Investig Drugs; 2009 Aug; 10(8):821-37. PubMed ID: 19649927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K; Kwo PY
    Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can boosted atazanavir induce hyperlipotrophy?
    Dellamonica P
    J Infect; 2006 Jun; 52(6):e189-90. PubMed ID: 16239035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic.
    Thomson JA; Perni RB
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):606-17. PubMed ID: 17002221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VX-950 (Vertex/Mitsubishi).
    Summa V
    Curr Opin Investig Drugs; 2005 Aug; 6(8):831-7. PubMed ID: 16121690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on hepatitis. HCV protease inhibitor does well in early clinical trial.
    Carter M
    IAPAC Mon; 2006 Feb; 12(2):50-1. PubMed ID: 17252625
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating hepatitis C in lower-income countries.
    Jayasekera CR; Barry M; Roberts LR; Nguyen MH
    N Engl J Med; 2014 May; 370(20):1869-71. PubMed ID: 24720680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.